QNTMQuantum Biopharma Ltd. Class B Subordinate Voting Shares
3.440USDMkt Cap: 22.12M $P/E: —3d ago
Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develo…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap22.12M $
Enterprise Value15.77M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-26.18M $
Revenue/Share—
Last Price3.440 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.44
PEG—
EV/EBITDA-1.34
EV/Revenue—
P/S—
P/B33.73
EPS (TTM)-7.54
EPS (Forward)-7.80
52W Range
3.35039% of range3.580
52W High3.580 USD
52W Low3.350 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-378.01%
ROA-234.53%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.24M $
CapEx (TTM)—
FCF Margin—
FCF Yield-23.51%
Net Debt-2.89M $
Net Debt/EBITDA0.25
Balance Sheet
Debt/Equity0.27
Current Ratio1.20
Quick Ratio0.48
Book Value/Sh0.1020 USD
Cash/Share0.6620 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:65
Split DateAug 15, 2024
Analyst Consensus
Rating—
Target (Mean)12.66 USD
Upside (mean)+268.2%
Target Range12.66 USD – 12.66 USD
# Analysts1
Ownership
Shares Out.6.43M
Float5.43M
Insiders9.78%
Institutions9.79%
Short Interest
Short Ratio3.4d
Short % Float5.21%
Short % Out.4.72%
Shares Short303.79K
Short (prev mo.)358.23K
Technical
SMA 503.414 (+0.8%)
SMA 2005.237 (-34.3%)
Beta—
S&P 52W Chg21.00%
Avg Vol (30d)136.72K
Avg Vol (10d)501.55K
Technical Indicators
RSI (14)51.4
MACD0.0306
MACD Signal-0.0206
MACD Hist.+0.0512
BB Upper3.862 USD
BB Middle3.248 USD
BB Lower2.635 USD
BB Width37.80%
ATR (14)0.3900 USD
Vol Ratio (20d)0.47x